Health Catalyst, Inc. (HCAT) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of Health Catalyst, Inc. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HCAT
Health Catalyst, Inc.
$1.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HCAT vs PYXS
growth of $100 · dividends reinvested · last 5yHCAT -96.4% (-48.6%/yr)PYXS -83.0% (-29.9%/yr)PYXS compounded faster over this window
HCAT PYXS
HCAT vs PYXS: by the numbers
- •HCAT is the larger company ($131M vs $128M market cap).
- •Both run net losses; HCAT's is the smaller (-90.61% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | HCAT | PYXS |
|---|---|---|
| P/S ratio | 0.45 | 11.59 |
| P/B ratio | 1.30 | 11.19 |
| EV / EBITDA | 74.38 | N/A |
| FCF yield | 9.99% | N/A |
Profitability
| Metric | HCAT | PYXS |
|---|---|---|
| Gross margin | 33.47% | 82.77% |
| Operating margin | -11.60% | -609.18% |
| Net margin | -90.61% | -803.83% |
| ROE | -262.64% | -775.59% |
| ROIC | -21.42% | -314.66% |
Growth (annualized)
| Metric | HCAT | PYXS |
|---|---|---|
| Revenue CAGR (5Y) | 6.24% | N/A |
| Total return CAGR (5Y) | -48.35% | N/A |
Go deeper
Dig into the metrics
Health Catalyst ROEPyxis Oncology ROEHealth Catalyst operating marginPyxis Oncology operating marginHealth Catalyst revenue growthPyxis Oncology revenue growthHealth Catalyst free cash flowPyxis Oncology free cash flow
Health Catalyst & Pyxis Oncology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.